GlassScriptPhysician profile
Melinda Shoemaker
NPI 1346247533
$5,086.08
in general payments reported to CMS, 2019-2025
31 companies · $1,182 in 2025
The $1,182 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $226 · 2021: $443 · 2022: $1,264 · 2023: $914 · 2024: $774 · 2025: $1,182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,870.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,434.53 | 2019-2025 | Puraply Wound Matrix, Novachor, Apligraf |
| Abbvie INC. | $723.87 | 2021-2023 | Dalvance |
| Averitas Pharma INC. | $347.35 | 2023-2025 | Qutenza |
| Treace Medical Concepts, INC. | $344.69 | 2024-2025 | |
| Smith+Nephew, INC. | $318.91 | 2019-2025 | Collagenase Santyl, Grafix Pl |
| Biotissue Holdings INC. | $267.89 | 2024-2025 | |
| Grt US Holding, INC. | $244.94 | 2022 | |
| Paratek Pharmaceuticals, INC. | $210.06 | 2022-2025 | Nuzyra |
| Musculoskeletal Transplant Foundation INC. | $181.78 | 2020 | |
| Ets Wound Care LLC | $172.87 | 2023-2025 | Mirragen Advanced Wound Matrix |
| Convatec INC. | $122.87 | 2023-2024 | |
| Innovation Technologies INC | $112.99 | 2023 | Irrisept |
| Polynovo North America LLC | $78.49 | 2022-2023 | |
| Acera Surgical, INC. | $69.00 | 2022 | |
| Abbott Laboratories | $46.24 | 2023-2024 | Proclaim |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $39.99 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Stryker Corporation | $36.12 | 2019 | |
| Solventum Corporation | $34.27 | 2024-2025 | 3m Cavilon, Kerramax Care, Activ.A.C. |
| Bioventus LLC | $32.13 | 2022 | |
| Horizon Therapeutics Plc | $31.31 | 2019-2021 | |
| Depuy Synthes Sales INC. | $26.69 | 2024 | Fibulink |
| Reprise Biomedical, INC. | $25.44 | 2024 | Miro3d |
| Medtronic, INC. | $23.51 | 2025 | Intellis Adaptivestim |
| Alfasigma USA, INC. | $22.36 | 2022 | |
| Melinta Therapeutics, LLC | $22.32 | 2022 | |
| Zimmer Biomet Holdings, INC. | $21.61 | 2021 | |
| Kci USA, INC. | $20.66 | 2020 | |
| Janssen Pharmaceuticals, INC | $18.81 | 2019 | |
| Merck Sharp & Dohme LLC | $18.58 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.91 | 2019 | |
| Allergan, INC. | $17.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melinda Shoemaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.